QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,203 signal articles · 495 in last 24h · 104,096 total before filter · latest 28m ago
495last 24h
2493last 7d
472● bullish (7d)
250● bearish (7d)
198publishers
AllMacro217Earnings1475M&A142Regulatory15Product6Analyst29
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Bloomberg3h agoneutral
Ares Eyes $2 Billion Loan Deal in Slow Year for Private Credit

(Bloomberg) -- Ares Management Corp. is leading a $2.2 billion direct loan to help finance a healthcare services acquisition, in one of the biggest deals since the private credit market was roiled by record redemptions this year.Most Read from BloombergSpaceX’s AI Splurge Puts a Damper on First Earnings After IPOTrump Says Iran Talks Going Well as Hopes Rise for Hormuz DealChina’s AI Blitz Creates ‘Death Zone’ for Rival US Model MakersTaco Bell Met With Michigan on Parasite Weeks Before RecallBe

SpaceX shares tumble despite earnings beat
CoinDesk3h agoneutralVIDEO
SpaceX shares tumble despite earnings beat

SpaceX reported its first quarterly results as a public company, beating on revenue but falling 11% as investors focused on heavy capital spending. Its 18,712 bitcoin lost roughly $195 million in value during the quarter. CoinDesk's Jennifer Sanasie hosts "CoinDesk Daily."

Wall Street Isn't Worried About SpaceX Price Declines
Barrons.com3h agoneutral
Wall Street Isn't Worried About SpaceX Price Declines

SpaceX stock has been weak for weeks. Analysts are sticking with their price targets. The average analyst price target for SpaceX stock is about $227 a share, according to FactSet, down $1 since SpaceX reported better-than-expected second-quarter numbers on Tuesday evening.

Big Tech's blowout profits hide an uncomfortable truth
TheStreet4h agoneutral
Big Tech's blowout profits hide an uncomfortable truth

Big Tech just closed out its second-quarter 2026 earnings season, and the results looked, on paper, like a triumph. Microsoft, Amazon, and Alphabet all posted numbers that blew past Wall Street's estimates, and headlines celebrated growth rates that haven't been seen in years. Dig one layer deeper, ...

💬 Money Quote: Novo Nordisk CEO
The Wall Street Journal4h agoneutral
💬 Money Quote: Novo Nordisk CEO

📣"I don't know the needs of the two competitors that are right now trying to talk to each other, but we don't see a need for a transformative M&A right now." —Mike Doustdar, CEO of Ozempic maker Novo Nordisk in an interview with the Journal, referring to a recent Financial Times report that AstraZeneca and Bristol Myers Squibb held talks over a tie-up.